Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.

Weight-loss medications surged in popularity this year. A survey from Kaiser Family Foundation found one in eight adults have taken drugs like Ozempic, Wegovy and Mounjaro. Demand for the drugs has ...

Ozempic and Wegovy, made by Novo, are on track to become the world’s top-selling drugs by 2025. Yet in 2024, ‘Wegovy Wednesday’ had already become one of the biggest weight-loss trends to sweep the ...

Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also ...

Not at all. Novo Nordisk's investigational weight loss therapy, CagriSema, combines semaglutide (the active ingredient in ...

Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down ...

Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

DOGE co-chair Elon Musk shocked his followers on Christmas Day by posting a tweet of his trimmed-down self in a Santa outfit.

Pennsylvania's Medicaid spending per enrollee on Wegovy, Zepbound, and other anti-obesity drugs was third-highest in the ...

Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of ...

The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.